Vincent Dagenais-Beaulé
- Professeur invité
-
Faculté de pharmacie
Web : ResearchGate
Web : LinkedIn
Pharm.D.
2014
M.Sc.
2015
Affiliated institutions
Institut Lady Davis de de recherche médicale (ILD) de Hôpital général juif de Montréal (HGM)
Education Programs
- Health Sciences
- Health Sciences
Courses
- PAP1139 Soins pharmaceutiques : psychiatrie
- PHA2220 Le pharmacien-conseil
Expertises
Responsabilities and outreach Expand all Collapse all
Student supervision Expand all Collapse all
Publications Expand all Collapse all
Fontaine J, Chin E, Provencher J, Rainone A, Wazzan D, Roy C, Rej S, Lordkipanidze M, Dagenais-Beaulé V, Assessing cardiometabolic parameter monitoring in inpatients taking a second-generation antipsychotic: The CAMI-SGA study – a cross-sectional study BMJ Open 2022;12:e055454. doi: 10.1136/bmjopen-2021-055454
Dagenais-Beaulé V., Rafizadeh R., Zhou T, co-editors. Antipsychotics. Dans: Procyshyn R., Bezchlibnyk-Butler KZ, Jeffries JJ, editors. Clinical Handbook of Psychotropic Drugs, 24th edition. Boston: Hogrefe Publishing Corporation; 2021.
Dagenais-Beaulé V., Risperidone is not only a prodrug: psychosis induced by medication switch from risperidone to paliperidone - a case report. Eur J Hosp Pharm. 2021
Dagenais-Beaulé V., Tourigny J.-F., Papillon-Ferland L. Opioid Use and Pain Control in the Elderly After Elective or Urgent Orthopaedic Surgery: A Retrospective Cohort Study, Clin Drug Investig. 2019 Mar ;39(3):301-308
Vincent P., Masson V., Dagenais-Beaulé V., Lessard S., David P.-M., Claveau M., Dagenais C. Comment le pharmacien peut-il contribuer à prévenir le suicide ? Québec Pharmacie. Octobre 2018. Disponible www.professionsante.ca/files/2018/10/09_PAQ_201810_PDF.pdf
Communications Expand all Collapse all
Dagenais-Beaulé V, Schizophrénie : Principes de base, dans :Trait Pharmacien, baladodiffusion, Association des Pharmaciens en établissement de santé, 2021-12-06. Disponible : https://soundcloud.com/trait-pharmacien/episode-53-schizophrenie-principes-de-base
Browse this profile on: